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Abstract The new concept of mammalian sex maintenance establishes that particular key genes
must remain active in the differentiated gonads to avoid genetic sex reprogramming, as described
in adult ovaries after Foxl2 ablation. Dmrt1 plays a similar role in postnatal testes, but the
mechanism of adult testis maintenance remains mostly unknown. Sox9 and Sox8 are required for
postnatal male fertility, but their role in the adult testis has not been investigated. Here we show
that after ablation of Sox9 in Sertoli cells of adult, fertile Sox8-/- mice, testis-to-ovary genetic
reprogramming occurs and Sertoli cells transdifferentiate into granulosa-like cells. The process of
testis regression culminates in complete degeneration of the seminiferous tubules, which become
acellular, empty spaces among the extant Leydig cells. DMRT1 protein only remains in non-mutant
cells, showing that SOX9/8 maintain Dmrt1 expression in the adult testis. Also, Sox9/8 warrant
testis integrity by controlling the expression of structural proteins and protecting Sertoli cells from
early apoptosis. Concluding, this study shows that, in addition to its crucial role in testis
development, Sox9, together with Sox8 and coordinately with Dmrt1, also controls adult testis
maintenance.
DOI: 10.7554/eLife.15635.001
Introduction
Sox genes encode an important group of transcription factors with relevant roles in many aspects of
pre- and post-natal development of vertebrates and other animal taxa. There are 20 Sox genes in ver-
tebrates, which are classified into 9 groups. Sox8, Sox9, and Sox10 (SoxE group) are involved in many
developmental processes (reviewed in Lefebvre et al., 2007). All three SoxE genes are expressed dur-
ing testis development, Sox9 being essential for testis determination and Sox9/Sox8 necessary for
subsequent embryonic differentiation (Chaboissier, 2004, Barrionuevo et al., 2006,
Barrionuevo et al., 2009). Sox10 can substitute for Sox9 during testis determination (Polanco et al.,
2010). Undifferentiated gonads have the inherent potential to develop into two completely different
organs, either as testes or as ovaries. The decision as to which fate to follow depends on the presence/
absence of sex-specific factors. In the male, the Y-linked, mammalian sex-determining factor, SRY,
upregulates SOX9 which triggers testis differentiation, whereas in the female, the WNT/b -catenin
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signaling pathway becomes active and induces ovarian development (Sekido and Lovell-Badge,
2008; reviewed in Svingen and Koopman, 2013; Sekido and Lovell-Badge, 2013). Both pathways
antagonize each other: the loss of either SRY or SOX9 leads to the formation of XY ovaries
(Berta et al., 1990; Foster et al., 1994;Wagner et al., 1994) whereas the absence of WNT-signaling
molecules such as WNT4 or RSPO1 causes XX sex reversal (Vainio et al., 1999; Parma et al., 2006).
Similarly, gain-of-function experiments confirmed this antagonism, as either upregulation of the testis
promoting genes Sox9 or Dmrt1 in the XX bipotential gonad (Bishop et al., 2000; Vidal et al., 2001;
Zhao et al., 2015) or ectopic activation of the canonical WNT signaling pathway in the XY bipotential
gonad (Maatouk et al., 2008) leads to XX and XY sex reversal, respectively. Furthermore, Sertoli cell-
specific conditional inactivation of Sox9 on a Sox8-/- background at embryonic day 13.5 (E13.5), two
days after the sex determination stage, leads to Dmrt1 downregulation with upregulation of the ovar-
ian-specific genes Wnt4, Rspo1 and Foxl2 (Barrionuevo et al., 2009; Georg et al., 2012). Similarly,
Sertoli cell-specific ablation of Dmrt1 at the same stage (E13.5) results in ectopic expression of Foxl2
by postnatal day 14 (P14) and to Sox9 downregulation by P28, including male-to-female genetic
reprogramming, as revealed by mRNA profiling (Matson et al., 2011a). Again, gain-of-function
experiments confirmed the existence of sexual antagonism after the sex determination period, as con-
ditional stabilization of b-catenin in differentiated embryonic Sertoli cells (E13.5, Amh-Cre) resulted in
testis cord disruption (Chang et al., 2008). The male-vs-female genetic antagonism also persists in the
adult ovary. The finding that in adult fertile females granulosa cells transdifferentiate into Sertoli-like
cells after Foxl2 ablation revealed that terminally differentiated female somatic cells require perma-
nent repression of the male-promoting factors to maintain correct identity and function
(Uhlenhaut et al., 2009). Furthermore, transgenic expression of Dmrt1 in the adult ovary silenced
Foxl2 and transdifferentiated granulosa cells into Sertoli-like, Sox9-expressing cells (Lindeman et al.,
2015).
Regarding the adult testis, a similar phenomenon appears to occur in fully functional Sertoli cells
after Dmrt1 ablation (Matson et al., 2011a). In addition to cells with a Sertoli cell morphology express-
ing both SOX9 and FOXL2, some cells with typical granulosa cell features were also observed, includ-
ing the absence of SOX9 and the presence of FOXL2. However, Sertoli-to-granulosa cell
transdifferentiation was not unambiguously documented, as the authors used an inducible ubiquitous
promoter (UBC-CreERT2) for Dmrt1 ablation in adult Sertoli cells and the possible existence of genetic
reprogramming was not investigated as no mRNA profiling was performed in adult mutant testes.
eLife digest Scientists thought for years that the ovaries and testes are fully developed, stable
organs that cannot change their structure and function in mature mammals. However, more recent
studies have shown that a gene called Foxl2 is active throughout life to prevent ovary cells from
becoming more like the Sertoli cells present in the testes. Similarly, a gene called Dmrt1 keeps
Sertoli cells from becoming more like ovary cells after birth.
Scientists don’t yet know all the details about how Dmrt1 prevents testes from becoming more
ovary-like. For example, do genes that help testes develop in the embryo (which include two genes
called Sox8 and Sox9) play a role in maintaining the adult testes?
Barrionuevo, Hurtado, Kim et al. have now genetically engineered adult male mice to lack the
Sox8 and Sox9 genes. The Sertoli cells in the testes of these mice gradually lost their key
characteristics and ultimately died. During this process, the testes cells took on certain
characteristics that made them more ovary-like: for example, the ovary-maintaining Foxl2 gene was
activated in the Sertoli cells.
Eventually, the structures in the testes that produce sperm degenerate and are replaced by
empty space in the genetically engineered mice. This happens because the Sox8 and Sox9 genes
control the production of proteins that maintain these structures. In addition, these genes also
protect the Sertoli cells from self-destructing, and the testes-maintaining Dmrt1 gene is not active
when Sox8 and Sox9 are missing. More studies are now needed to determine how Sox8 and Sox9
work with Dmrt1 to maintain the testes.
DOI: 10.7554/eLife.15635.002
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Figure 1. Sox9 and Sox8 maintain the function and integrity of the adult mouse testis. (A) Diagram illustrating the time course of TX administration.
Mice were fed with a TX-supplemented diet during one month, between P60 (0 datx) and P90 (30 datx). After this period, mice were fed with a normal
Figure 1 continued on next page
Barrionuevo et al. eLife 2016;5:e15635. DOI: 10.7554/eLife.15635 3 of 23
Research article Developmental biology and stem cells
Nothing is known on the role of SOX9 in the adult testis, where it is expressed by Sertoli cells in a
spermatogenic stage-dependent manner in several mammalian species (Fro¨jdman et al., 2000;
Dadhich et al., 2011; Massoud et al., 2014). Here we report the use of two Sertoli-cell-specific Cre
lines (Wt1-CreERT2 and Sox9-CreERT2) to induce Sox9 ablation on a Sox8-/- background in the adult
testis, starting at postnatal day 60 (P60). We show that Sox9/8 Sertoli cell-specific knockout (SC-DKO)
testes undergo testis-to-ovary genetic reprogramming and Sertoli-to-granulosa cell transdifferentia-
tion. The process is retinoic acid (RA)-mediated and occurs as a consequence of Dmrt1 downregula-
tion. SOX9/8 are necessary to maintain Dmrt1 expression and thus to prevent Foxl2 expression in the
adult testis. Furthermore, double mutant testes exhibited complete degeneration of the seminiferous
tubules and increased apoptosis, indicating that SOX9/8 are continually required for the maintenance
of testis integrityy.
Results
Sox9 and Sox8 are necessary for maintaining the function and integrity
of adult seminiferous tubules
To investigate the function of Sox9 and Sox8 in the adult testis, we induced the Sertoli cell-specific
ablation of Sox9 in adult Sox8 null mutant mice using the tamoxifen (TX)-inducible Cre-loxP
Figure 1 continued
diet. The main stages studied in this work are depicted. (B) Analysis of the Cre-recombination efficiency in Sox9/8 DKO (Sox9) mice at p150 (90 datx). (a)
EYFP is widely expressed in SC-DKO testis cords. At the same stage, the number of SOX9+ cells in the control (Sox9f/f;Sox8-/-) (b) is clearly higher than
in the mutant (c). (d) Comparisons of the mean number of SOX9+ cells per transversal testis tubule section in control (Sox9f/f;Sox8-/-) and mutant testes.
All pairwise comparisons provided statistically significant differences (two tail test, p<0.001 in all cases). (C) Time-course of testis regression in Sox9/8
DKO (Sox9) mice. Representative micrographs are shown for both TX-treated controls (Sox9f/f;Sox8-/-) (a–f) and Sox9/8 DKO (Sox9) mice (g–l) between
p70 (10 datx) and P180 (120 datx). T, normal seminiferous tubules; arrows indicate desquamated germ cells; asterisks mark testis tubules showing signs
of degeneration (from enlarged lumen to Sertoli cell-only condition); STC, shrunken testis cords; ATC acellular testis cords. (D) Analysis of somatic (a–i
and m–n) and germ cell (j–l) molecular markers. Immunofluorescence for LAMININ (a–c), ACTA2 (d–f) and CLAUDIN11 (g– i) in both P150 (90 datx) TX-
treated control (Sox9f/f;Sox8-/-) (a, d and g) and SC-DKO testes at P150 (90 datx) (b, e and h) and P180 (120 datx) (c, f and i). Arrows mark seminiferous
tubule expression of ACTA2 (d and e) and Claudin11 (g and h); arrowheads mark arterial expression of ACTA2 (d–f). Asterisks mark testis cords lacking
ACTA2 (f) or Claudin11 (i) expression. Double immunofluorescence for PCNA and DMC1 showing the time-course of spermatogenesis reduction in the
testes of both P150 (90 datx) TX-treated control (Sox9f/f;Sox8-/-) (j) and P90 (30 datx) and P150 (90 datx) SC-DKO mice (k,l). Arrows mark spermatocytes
showing colocalization of the two proteins; arrowheads mark proliferating spermatogonia expressing PCNA but not DMC1. Expression of P450SCC
(green fluorescence) in Leydig cells of both TX-treated control (Sox9f/f;Sox8-/-) (m) and SC-DKO (n) testes at P150 (90 datx). Scale bars in Bc, Cl and Dn
represent 100 mm for pictures in B, 50 mm for those in C and 50 mm for those in D, respectively.
DOI: 10.7554/eLife.15635.003
The following source data and figure supplements are available for figure 1:
Source data 1. Comparison of the number of SOX9+ cells per testis tubule in both SC-DKO mutants and TX-treated controls (Sox9f/f;Sox8-/-).
DOI: 10.7554/eLife.15635.004
Figure supplement 1. Analysis of the CRE-recombination efficiency in SC-DKO mice.
DOI: 10.7554/eLife.15635.005
Figure supplement 2. Redundant role for Sox9 and Sox8 in the maintenance of adult testis cord architecture.
DOI: 10.7554/eLife.15635.006
Figure supplement 3. Relative abundance of the most relevant morphological features observed in the testes of P120 control and Sox9/8 mutant mice
differing in the number of Sox9/8 mutant alleles 60 days after TX administration during 5 days with a feeding-gauge needle.
DOI: 10.7554/eLife.15635.007
Figure supplement 4. Time course of the testis phenotype of control and SC-DKO (Wt1) mice.
DOI: 10.7554/eLife.15635.008
Figure supplement 5. Relative abundance of the most relevant morphological features observed throughout the timecourse of testis regression in
double Sox8/Sox9 mutant mice.
DOI: 10.7554/eLife.15635.009
Figure supplement 6. Functional status of the BTB in Sox9/8 DKO testes.
DOI: 10.7554/eLife.15635.010
Figure supplement 7. Expression bar plots of two adult Leydig cell markers.
DOI: 10.7554/eLife.15635.011
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mutagenesis system. We used two different CreERT2 mouse lines, a Wt1 knock-in line (Wt1-
CreERT2; Zhou et al, 2008), and a Sox9 BAC-transgenic line (Sox9-CreERT2; Kopp et al, 2011). To
check the Cre recombination efficiency, we introduced the R26R-EYFP allele in both Sox9-CreERT2
and Wt1-CreERT2 double homozygous Sox9/8 knockout (DKO) mutants. Sox8/9 DKO mice fed with
a TX-supplemented diet for a maximun of 30 days starting at P60 (Figure 1A) showed EYFP expres-
sion in a reduced number of Sertoli cells already 10 days after the beginning of TX administration
(10 datx, P70) in the two CreERT2 lines. The number of EYFP+ Sertoli cells increased in both lines at
later time-points, the Sox9-CreERT2 line showing always a higher number of positive cells than the
Wt1-CreERT2 line. From P150 (90 datx) on, the EYFP signal occupied the whole area of the seminif-
erous tubule section (Figure 1Ba, Figure 1—figure supplement 1A). However, the fact that the
cytoplasm of Sertoli cells is very large and complex in shape, together with the severe shrinkage that
Sox9/8 SC-DKO seminiferous tubules have undergone by this time, made it very difficult to identify
individual EYFP+ cells in these testes. Hence we performed immunofluorescence for SOX9 and
counted the number of SOX9+ cells per transversal testis cord section. At P90 (30 datx) all seminifer-
ous tubules still contained many positive cells, but the number was clearly reduced by P120 (60 datx)
and even more by P150 (90 datx), when some testis cords were completely devoid of SOX9+cells
(Figure 1Bb–c, Figure 1 —figure supplement 1B). At this later stage, the number of SOX9+ cells
per seminiferous tubule cross section decreased to 15.39 ± 3.36 (37% reduction) in the testes of the
Wt1-CreERT2; Sox9f/f; Sox8-/- [Sox9/8 DKO (Wt1)] mice and to 7.49 ± 3.61 (69% reduction) in those
of the Sox9-CreERT2; Sox9f/f; Sox8-/- [Sox9/8 DKO (Sox9)] mice, when compared to controls (24.31 ±
2.94) (Figure 1Bd, Figure 1—source data 1). The fact that the number of recombinant Sertoli cells
lacking Sox9 in these mutant mice continues decreasing for several weeks after the end of the period
of TX administration (30 days) suggests that many newly recombined cells appear after that time
(persistence of TX in the body) and that perhaps either the Sox9 transcript or the protein, or both,
are very stable in adult Sertoli cells, so that the gene product may remain for days or weeks in the
cell after the gene ablation event. We also found that the reduction of SOX9+ cells varied among
testis cords and among animals. We selected the most affected regions of the most affected individ-
uals for further analyses.
Consistent with the situation reported for embryonic stages of development (Barrionuevo et al.,
2009), we observed that the testis phenotype of the different Sox9/8 compound mutants increased
in severity with the number of Sox9/8 mutant alleles (Figure 1—figure supplement 2 and 3).
O’Bryan et al. (2008) reported a Sox8-/- mouse line in which a progressive deregulation of sper-
matogenesis occurred and where male mice became sterile by P150. In contrast, our Sox8 mutants
(Sock et al., 2001) do not show such a severe testicular phenotype and males are normally fertile
even at P180. At the histological level, our Sox8-/- mice appeared normal until P120, but showed
signs of germ cell desquamation (sloughing) afterwards (Figure 1—figure supplement 4a–f).
Genetic background differences between the two Sox8-/- lines may explain these phenotypic dis-
crepancies. TX-treated controls were similar to untreated males, except between P80 (20 datx) and
P120 (60 datx) and mainly at P90 (30 datx), when they showed some degenerating seminiferous
tubules, but recovered afterwards (Figure 1Ca–f, Figure 1—figure supplement 4a–l). Testes in
Sox9/8 DKO (Sox9) mice were similar to the TX-treated controls at P70 (10 datx) except for a few
testis tubules with enlarged lumen (Figure 1Cg). At P80 (20datx), only few seminiferous tubules
showed signs of degeneration (shrinkage and germ cell depletion), whereas this was more frequent
by P90 (30 datx). In many cases, Sertoli cell-only tubules were visible (Figure 1Ch,i). By P120 (60
datx), tubules had become solid testis cords whose diameter appeared even more reduced at P150
(90 datx) (Figure 1Cj,k). While some mice continued to exhibit this phenotype at P180 (120 datx), a
subset of mice in this group was more affected. In these latter mice Sertoli and germ cells had disap-
peared completely (Figure 1Cl). At later time points, all mice showed this severe testicular pheno-
type. This progressive degeneration of the testicular phenotype in Sox9/8 SC-DKO mice was evident
when we analyzed the relative abundance of the most relevant testicular morphological features
between P70 (10 datx) and P180 (120 datx) (Figure 1—figure supplement 5). In contrast, Leydig
cells appeared morphologically normal in mutant testes. Sox9/8 DKO (Wt1) mice exhibited a similar
testicular phenotype (Figure 1—figure supplement 4m–r). These results show that Sox8 and Sox9
alleles act redundantly in adult Sertoli cells and are necessary to maintain the integrity of the seminif-
erous tubules of functional testes.
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Functional status of both somatic and germ cells in testes with Sox9/8-
deficient Sertoli cells
To better define the mutant phenotype, we next studied the expression of several somatic and germ
cell markers. Laminin, a principal component of the basement membrane (Richardson et al., 1995)
persisted in both P150 (90 datx) and P180 (120 datx) testes of SC-DKO mice (Figure 1Db,c). Alpha
smooth muscle actin (Acta2) expressed by both peritubular myoid (PM) cells and arterialmuscle fibers
was detected in the testes of both TX-treated controls and P150 (90 datx) SC-DKO mice (Figure 1Dd,
e). In contrast, at P180 (120 datx), strong arterial ACTA2 signal persisted but that of PM cells was
almost undetectable (Figure 1Df). This shows that acellular cords in severely affected SC-DKO testes
have lost not only Sertoli and germ cells, but also PM cells. Claudin11 is a principal component of tight
junctions, the main junctional structures forming the blood-testis barrier (BTB). Cldn11 (the claudin11
gene) expression was similar between controls and double mutants before P150 (90 datx) (not shown),
but it was severely reduced by P150 (90 datx) and completely absent in P180 (120 datx) Sox9/8mutant
testes (Figure 1Dg–i), indicating that the BTB is not functional in these testes. To proof this assump-
tion, we tested the permeability of the BTB of P120 (60 datx) mice with a biotin tracer experiment
revealing that control testes had a functional BTB, whereas that of the mutant testes had become per-
meable (Figure 1—figure supplement 6). We also performed immunofluorescence for both PCNA,
which is expressed in mitotic spermatogonia as well as in zygotene and early pachytene, but not lepto-
tene spermatocytes (Chapman and Wolgemuth, 1994), and DMC1, a meiotic recombination protein
marking zygotene-pachytene spermatocytes (Yoshida et al., 1998). At P60 (30 datx), most mutant
seminiferous tubules exhibited a clear reduction of spermatogenic activity and some spermatocytes
were abnormally located in the inner region of the tubules (Figure 1Dk) and not at the periphery, as
seen in TX-treated control testes (Figure 1Dj). In P120 (60 datx) testes, spermatocytes were scarce
and only proliferating spermatogonia were seen in most testis tubules (not shown), while at P150 (90
datx), both spermatogonia and spermatocytes had disappeared in most tubules (Figure 1Dl). These
results indicate that spermatogenesis becomes disrupted in testes with Sertoli cells deficient for both
Sox9 and Sox8. Unlike other somatic cells, Leydig cells appear not to be seriously affected in testes
from Sox9/8 SC-DKO mice. These cells do not transdifferentiate into theca cells, as they never express
Foxl2 (as theca cells do; not shown), and maintain the steroidogenic function for a long time after Sox9
ablation, as deduced from the expression of P450scc, a cytochrome involved in the synthesis of testos-
terone (Figure 1Dm,n). Consistently, the testosterone-producing enzyme HSD17b3 and the marker
for adult functional Leydig cells Insl3 are expressed at high levels in the mutant testes (Figure 1—fig-
ure supplement 7).
Somatic testis-to-ovary genetic reprogramming in the absence of Sox9
and Sox8 in adult mouse testes
The loss of Foxl2 in adult granulosa cells results in a somatic ovary-to-testis genetic reprogramming
with granulosa-to-Sertoli cell transdifferentiation which includes Sox9 upregulation (Uhlenhaut et al.,
2009). Contrarily, Foxl2 is upregulated when Sox9 is ablated in embryonic Sertoli cells of Sox8 null
mutants after the sex-determination stage (Georg et al., 2012). To test whether a similar phenome-
non took place in our Sox9/8 SC-DKO mice, we carried out immunofluorescence for FOXL2. At P90
(30 datx), FOXL2 protein was almost completely absent from mutant testes. However, by P105 (45
datx), positive cells were present in almost all testis cords, and by P150 (90 datx), the most severely
affected mice showed many FOXL2-positive cells within almost all testis cords (Figure 2A, Figure 2—
figure supplement 1). These results show that transdifferentiation also occurs in adult Sox9/8 DKO
Sertoli cells. Accordingly, we performed a genome-wide transcriptome analysis of P150 untreated
control testis, P150 (90 datx) control and mutant testis and control ovary. Our results show that SC-
DKO testes exhibit a striking feminization of the testicular transcriptome. Figure 2B shows a Log2-
fold-change heat map including the 12,380 genes detected to have significant differential expression
between the five sample conditions (the complete list of genes with differential expression is shown
in Figure 2—source data 1). With the exception of a few gene clusters, most genes in mutant testes
adopted an ovary-like expression pattern (Figure 2B, Figure 2—figure supplement 2,
Supplementary file 1). Cluster analyses of all genes, both by replicates and by conditions, showed
that mutants are clustered together, with no clear distinction between Sox9-CreER and Wt1-CreER
lines (Figure 2—figure supplement 3). Similarly, pairwise gene sets with significant differential
Barrionuevo et al. eLife 2016;5:e15635. DOI: 10.7554/eLife.15635 6 of 23
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Figure 2. Genetic reprogramming in somatic cells of adult Sox9/8 SC-DKO (Sox9). (A) Expression of FOXL2 (green fluorescence) in P150 (90 datx) TX-
treated control (Sox9f/f;Sox8-/-) (a) and in Sox9/8 SC-DKO (Sox9) mouse testes analyzed at P90 (30 datx) (b), P105 (45 datx) (c), and P150 (90 datx) (d) as
well as in a P 90 control ovary (e). (B) Heatmap showing the 12,380 genes found to be differentially expressed at alpha < 0.005 when comparing control
(Sox9f/f) and mutant adult gonads. The log2(FPKM+1) of each gene in each condition has been divided by the corresponding value in control testis.
Figure 2 continued on next page
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expression at a < 0.05 demonstrated that the number of differentially expressed genes is higher
when mutants were compared with testis controls than when compared with ovary (Figure 2—figure
supplement 4A). Accordingly, the distance map is higher between mutant and control testis than
between mutant testis and ovary (Figure 2—figure supplement 4B). The same results were
obtained when comparing isoforms, transcription start sites or coding DNA sequences (not shown).
Expression heat maps for selected 39 ovarian somatic cell-specific genes and 33 oocyte-specific
genes selected using bioGPS (biogps.gnf.org) revealed that the cell reprogramming observed in the
SC-DKO testes only affects somatic cells (Figure 2C). Notably, bar plots for six genes known to be
adult granulosa cell markers showed that these genes were upregulated in the mutant Sertoli cells,
revealing an ovary-like expression pattern (Figure 2D). In addition, within the seminiferous cords of
SC-DKO testes we found a few FOXL2+ cells expressing the enzyme aromatase (Figure 2E). This is
evidence that, in addition to Foxl2, other genes normally expressed by granulosa cells are also tran-
scribed and translated in Sox9/8 SC-DKO testes.
Sertoli-to-granulosa cell transdifferentiation in adult Sox9/8 SC-DKO
testes
We next investigated the origin of the granulosa-like, FOXL2+ cells present in the Sox9/8 SC-DKO tes-
tes. Several pieces of evidence show that FOXL2+ cells in our mutant testes originate from Sox9/8 null
Sertoli cells. The two gene promoters we used to drive Cre expression (Sox9 andWt1) are Sertoli cell-
specific in the testis, indicating that transdifferentiation originates directly from this cell type. Impor-
tantly, we found that FOXL2+ cells always located inside testis cords with strong expression of the Cre-
recombination reporter EYFP (Figure 3A). We also analyzed the expression of WT1, a Sertoli cell
marker whose expression is maintained after Sox9/8 ablation in embryonic mouse Sertoli cells
(Barrionuevo et al., 2009), and that it is co-expressed with FOXL2 in granulosa cells of immature, but
not mature, follicles (Chun et al., 1999; Figure 3Ce). At P90 (30 datx) we observed many WT1+ Sertoli
cells that have already lost SOX9 (green cells, Figure 3Bb). The number of WT1+ SOX9- cells
decreased by P150 (90 datx) (Figure 3Bc), indicating that recombined Sertoli cells were being lost.
This decrease in the number of WT1+ SOX9- Sertoli cells coincides with an increase in the number of
FOXL2+ cells which either retain weak WT1-staining or are WT1- (Figure 3C), suggesting that FOXL2+
cells originate from cells previously expressing WT1, that is Sertoli cells. Altogether, these results indi-
cate that Sox9/8 SC-DKO testes experience a cell-autonomous Sertoli-to-granulosa cell transdifferen-
tiation which triggers the observed testis-to-ovary genetic reprogramming in these gonads.
Figure 2 continued
Gene expression has not been altered by the TX treatment. Red colors indicate genes upregulated with respect to their expression levels in control
testis and green colors indicate downregulated genes. (C) Expression heatmaps of selected ovarian somatic-specific and oocyte-specific genes.
(D) Expression bar plots of six relevant ovarian somatic-specific genes upregulated in mutant testes. (E) Aromatase (red) and FOXL2 (green)
immunofluorescence staining of TX-treated control (Sox9f/f;Sox8-/-) testis (a), mutant testes (b–d), and control ovary (e). Arrows mark reprogrammed
Sertoli cells showing simultaneous expression of Aromatase and FOXL2. Scale bar shown in Ae represents 150 mm in A and 75 mm in E.
DOI: 10.7554/eLife.15635.012
The following source data and figure supplements are available for figure 2:
Source data 1. Genes with significant differential expression among untreated controls, TX-treated controls, Sox8/9 SC-DKO mutants and control ovary
at P150 (90 datx) identified from the bioinformatic analysis of our transcriptome.
DOI: 10.7554/eLife.15635.013
Figure supplement 1. Expression of Foxl2 in somatic cells of adult Sox9/8 DKO (Wt1).
DOI: 10.7554/eLife.15635.014
Figure supplement 2. Heatmaps showing the expression of genes involved in 8 selected pathways (A–H), relative to their expression in control testes.
DOI: 10.7554/eLife.15635.015
Figure supplement 3. Cluster analysis of (A) replicates and (B) conditions.
DOI: 10.7554/eLife.15635.016
Figure supplement 4. Quantification of genes with differential expression and Jensen–Shannon (JS) distances between conditions.
DOI: 10.7554/eLife.15635.017
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Sertoli-to-granulosa cell transdifferentiation is mediated by Dmrt1
downregulation in Sox9/8 SC-DKO testes
Since Sox9 is upregulated after Foxl2 ablation in adult granulosa cells (Uhlenhaut et al., 2009) and
downregulated after Dmrt1 ablation in embryonic Sertoli cells (Matson et al., 2011a), we investi-
gated the expression pattern of these two genes in the testes of the Sox9/8 SC-DKO mutants. We
found that cells coexpressing SOX9 and FOXL2 were rare at any stage analyzed [12 out of 203
FOXL2+ cells co-expressed SOX9 at P120 (60 datx)] (Figure 4A, Figure 4—figure supplement 1A),
indicating that Foxl2 upregulation requires previous elimination of both SOXE proteins. Next, we
examined the expression of both Sox9 and Dmrt1 in Sox9/8 SC-DKO testes. As Dmrt1 is expressed
in both Sertoli cells and spermatogonia of adult testes (Raymond et al., 2000), we used a third
marker, PCNA, that labels spermatogonia as well as zygotene and early pachytene spermatocytes.
Whereas all Sertoli cells in control testes showed strong staining for both DMRT1 and SOX9 (SS,
Figure 4Ba), mutant Sertoli cells showed varying degrees of both SOX9 and DMRT1 staining inten-
sity, although they normally paralleled each other in intensity. Therefore Sertoli cells with a weak
staining for both DMRT1 and SOX9 (WS) were also visible in these testes. Consistent with this, we
found a very reduced number of cells expressing only DMRT1 at P90 (30 datx) (Figure 4Bb–d, red
cells (arrow); SOX9- DMRT1+ PCNA-) and almost none at P120 (60 datx) (Figure 4Be–g). Further-
more, in P150 (90 datx) testes, which are almost devoid of germ cells, DMRT1 immunoreactivity was
almost exclusively restricted to SOX9+ cells (Figure 4—figure supplement 1B). Double WT1-DMRT1
staining confirmed that as early as at P90 (30 datx) many WT1+ cells (Sertoli cells) have already lost
DMRT1 expression (green cells in Figure 4Cb), showing that Dmrt1 is downregulated after Sox9
ablation and before Wt1 downregulation occurs in SC-DKO testes. In addition, as observed for
SOX9 and FOXL2 (see above), DMRT1 and FOXL2 only colocalize in a reduced number of cells in
the testes of our Sox9/8 SC-DKO mice [16 out of 127 FOXL2+ cells co-expressed DMRT1 at P120 (60
datx)] (Figure 4D, Figure 4—figure supplement 1C). Overall, these findings support the notion that
SOX9 and SOX8 are necessary for the maintenance of Dmrt1 expression in adult Sertoli cells and
that these testis-promoting factors negatively regulate Foxl2.
Figure 3. Identification of the somatic cells expressing FOXL2. (A) Double immunofluorescence for FOXL2 (green, nuclear) and EYFP (red, cytoplasmic)
(B) Double immunofluorescence for SOX9 and WT1 in P150 (90 datx) TX-treated control (Sox9f/f;Sox8-/-) testes (a) and Sox9/8 SC-DKO testes analyzed
at P90 (30 datx) (b) and P150 (90 datx) (c). Dashed lines delineate the seminiferous tubules contour. Arrows mark mutant cells expressing WT1 but not
SOX9. (C) Double immunofluorescence for FOXL2 and WT1 in both TX-treated control (Sox9f/f;Sox8-/-) (a) and Sox9/8 SC-DKO mutant testes analyzed
at P120 (60 datx) (b–d), as well as in a control ovary (e). Arrows point to mutant cells expressing both proteins. Scale bar in Ac represents 25 mm in A;
scale bar in Bc represents 25 mm in B; scale bar in Cd represents 25 mm in Ca–d and scale bar in Ce represents 100 mm.
DOI: 10.7554/eLife.15635.018
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Figure 4. Role of Dmrt1 in Sertoli-to-granulosa cell transdifferentiation. (A) Double immunofluorescence for SOX9 and FOXL2 in TX-treated control
(Sox9f/f;Sox8-/-) testis (a), Sox9/8 SC-DKO mutant testes analyzed at P105 (45 datx) and P150 (90 datx) (b,c) and a control ovary (d) (b’ is a higher
magnification of the area marked in b). Colocalization of SOX9 and FOXL2 was rare and the few observed cells showed weak fluorescence for both
proteins (arrowheads in b’). (B) Triple immunofluorescence for SOX9, DMRT1 and PCNA (germ cell marker) in P150 (90 datx) TX-treated control (Sox9f/f;
Sox8-/-) testes (a) and Sox9/8 SC-DKO mutant testes at P90 (30 datx) (b–d) and P120 (60 datx) (e-g). Different cell types can be identified: SS: Sertoli cells
with strong staining for both DMRT1 and SOX9 (SOX9+ DMRT1+ PCNA-; strong yellow); WS: Sertoli cells with weak staining for both DMRT1 and SOX9
(SOX9+ DMRT1+ PCNA-; pale yellow); SP: spermatocytes (SOX9- DMRT1- PCNA+; blue); SG: proliferating spermatogonia (SOX9- DMRT1+ PCNA+;
purple), arrow (SOX9- DMRT1+ PCNA-; red). Non-proliferating spermatogonia could be confused in Sox9/8 SC-DKO mice with recombined DMRT1+
SOX9- Sertoli cells in which SOX9 already disappeared, but the number of the former cell type is so low that they can be ignored. (C) Double
immunofluorescence for DMRT1 and WT1 in P90 (30 datx) TX-treated control (Sox9f/f;Sox8-/-) (a) and mutant testes (b). (D) Double immunofluorescence
for DMRT1 and FOXL2 in P150 (90 datx) TX-treated control (Sox9f/f;Sox8-/-) testis (a), Sox9/8 SC-DKO mutant testes (b–c) and control ovary (d) (b’ is a
Figure 4 continued on next page
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To further test this hypothesis, we compared the microarray data from P28 SC-Dmrt1 KO testes
reported by Matson et al. (2011b) with the RNA-seq data from our P150 (90 datx) SC-Sox9/8 DKO
testes, and plotted all mRNAs that resulted either downregulated or upregulated when compared to
control males in both datasets (Figure 5A, small blue dots). Nearly all genes strongly affected by the
loss of Dmrt1 were also affected by the loss of Sox9/8 (Figure 5A, Figure 5—source data 1). This
Figure 4 continued
higher magnification of the area marked in b). Colocalization of both proteins was rare (arrowheads in b’). Scale bar in Dd represent 50 mm in A and D;
scale bar in Bg represents 25 mm in B; scale bar in Cb represents 50 mm in C.
DOI: 10.7554/eLife.15635.019
The following figure supplement is available for figure 4:
Figure supplement 1. Role of Dmrt1 in Sertoli-to-granulosa cell transdifferentiation.
DOI: 10.7554/eLife.15635.020
Figure 5. Sox9 and Dmrt1 act in the same pathway during Sertoli-to-granulosa transdifferentiation. (A) Log2 fold change scatterplot comparing the
microarray data from the P28 SC-Dmrt1 KO testes reported by Matson et al., 2011b; GEO accession: GSE27261) with the RNA-seq data from our P150
(90 datx) SC-Sox9/8 DKO testes, including 8910 genes showing significant differential expression respect to normal testis in both Dmrt1 and Sox9/8
mutants (blue dots). Among these, green dots represent 24 genes belonging to the all-trans-retinoic acid-mediated apoptosis path and RA receptors-
mediated signaling from the PathCards database. Red triangle show 29 of the ovarian somatic specific genes included in Figure 2C. The names of
some relevant genes are indicated. Regression line is shown in red (intecept = 0.7112, slope = 1.0883). (B) Effect of the treatment of Sox9/8 SC-DKO
mice with WIN 18,644 on Sertoli-to-granulosa cell transdifferentiation. FOXL2-positive cells (green fluorescence) were much more abundant in untreated
(a) than in treated mutant testes (b). The number of positive cells per testis/cord section was 3.5-fold higher in untreated mice (c). The ACTA2 signal
(red fluorescence) permitted to delineate the testis cords in a and b. Scale bar in Bb represents 100 mm in Ba–b.
DOI: 10.7554/eLife.15635.021
The following source data is available for figure 5:
Source data 1. List of 8910 genes showing significant differential expression respect to normal testis in both Dmrt1 and Sox9/8 mutants.
DOI: 10.7554/eLife.15635.022
Source data 2. Log2 fold change of expression of both Dmrt1 and Sox9/8 mutants respect to controls in a set of genes belonging to the all-trans-reti-
noic acid-mediated apoptosis path and RA receptors-mediated signaling from the PathCards database.
DOI: 10.7554/eLife.15635.023
Source data 3. Comparison of the number of FOXL2+ cells per transversal testis cord section in Sox9/8 DKO (Sox9) WIN 18,446-treated mice and vehi-
cle-injected controls
DOI: 10.7554/eLife.15635.024
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finding suggests that both Dmrt1 and Sox9/8 act in the same pathway, although the possibility also
exists that this coincidence between both gene expression patterns could be a secondary effect of the
change in relative numbers of cell types in the SC-Sox9/8 DKO testes. Among the genes upregulated
in both experiments (upper right quadrant in Figure 5A), we found 29 somatic ovarian-specific genes
including female promoting genes such as Foxl2, Wnt4, Rspo1, Fst, Fshr (Figure 5A, red triangles).
Also, a set of genes were upregulated in Dmrt1 mutants and downregulated in Sox9/8 mutants
(upper-left quadrant in Figure 5A), which may be a consequence of 1) the age-differences between
the two compared sample sets, 2) the incomplete efficiency of Sox9 inactivation of our conditional SC-
Sox9 KO, or 3) the existence of additional roles for Sox9/8 and/or Dmrt1 in the adult testis.
It was recently reported (Minkina et al., 2014) that DMRT1 functions by protecting male gonadal
cells from retinoid acid (RA)-dependent sexual transdifferentiation and that this process could be
inhibited by blocking intra-tubular RA synthesis in the Dmrt1-mutant testes. By comparing the
mRNA profiling of SC-Dmrt1 KO and SC-Sox9/8 DKO testes, we found a set of genes belonging to
the RA-signaling pathway showing similar misexpression in both mutants (Figure 5A, green dots,
Figure 5—source data 2). As Dmrt1 is downregulated in the Sox9/8 SC-DKO testes, we hypothe-
sized that reducing RA levels in our SoxE mutants should also affect the transdifferentiation process.
To test this, we treated adult SC-DKO mice with the retinaldehyde dehydrogenase inhibitor WIN
18,446 just when the first FOXL2-positive cells are detected. We found a 3.5-fold reduction in the
number of FOXL2-positive cells per testis cord section in the WIN 18,446-treated mice (1.80 ± 2.03),
compared to the vehicle (DMSO)-injected controls (6.57 ± 3.52; p<0.001; Figure 5B, Figure 5—
Figure 6. Incidence of apoptosis in Sox9/8 SC-DKO testes. (A) TUNEL staining in testis sections of TX-treated control (Sox9f/f;Sox8-/-) at P120 (60 datx)
(a) and Sox9/8 SC-DKO at different time-points (b–d). (B) Double immunofluorescence for TUNEL and three molecular markers: SOX9 [a, (P90 (30datx))
and b, (P150 (90 datx))], FOXL2 (c, P120 (60 datx)), and WT1 (d, P90 (30 datx)). Arrows in b and d mark cells showing coexpression of the two proteins.
Scale bar in Ac represents 100 mm for Aa–c; scale bar in Ad represents 50 mm; scale bar in Bd represents 50 mm in B.
DOI: 10.7554/eLife.15635.025
The following source data is available for figure 6:
Source data 1. Comparison of the number of TUNEL-positive cells per section area unit in both SC-DKO mutants and TX-treated controls.
DOI: 10.7554/eLife.15635.026
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source data 3). Hence, as reported for Dmrt1 SC-KO mice (Minkina et al., 2014), the process of
Sertoli-to-granulosa cell transdifferentiation seems to be also inhibited when RA levels were reduced
in our study model.
SOX9 and SOX8 act as anti-apoptotic factors in adult Sertoli cells
Coinciding roughly with the end of TX treatment, Sox9/8 SC-DKO testes begin to progressively
degenerate, as evidenced by shrinkage of the seminiferous tubules, which in the most severely
affected mice reach an extreme degree of tubular involution and become acellular testis cords. A
possible explanation for the loss of tubular somatic cells is that apoptosis is operating in these tes-
tes. TUNEL assay revealed apoptotic cells mainly inside the testis tubules/cords, showing that inter-
stitial cells (mostly Leydig cells) are not seriously affected. The numbers of TUNEL-positive cells
counted in a total area of 11.55 mm2 between P90 (30 datx) and P120 (60 datx) in both SC-
DKO mutants (370 cells for the Wt1-CreERT2 line and 488 cells for the Sox9-CreERT2 line) were sig-
nificantly higher than those found in TX-treated control testes (120 cells; goodness of fit test p<2.2e-
16 in both cases; Figure 6Aa–c, Figure 6—source data 1). The presence of abundant apoptotic
bodies at P150 (90 datx) (Figure 6Ad) documents the massive cell death that had occurred during
previous stages in the Sox9/8 SC-DKO mice.
To identify the cell types undergoing apoptosis, we combined TUNEL staining with immunofluo-
rescence for several molecular markers. Neither SOX9- nor FOXL2-expressing cells were observed to
be apoptotic in mutant testes before P120 (60 datx) (Figure 6Ba,c), but SOX9+ cells were found to
be apoptotic in the P150 (90 datx) testes (Figure 6Bb). In contrast, we observed apoptotic cells
expressing WT1 as early as P90 (30 datx) (Figure 6Bd), indicating that apoptosis mainly affects
recombined Sertoli cells in which Sox9 had been ablated but Foxl2 had not yet been upregulated.
Altogether, these findings suggest that testis regression in Sox9/8 mutants occurs in two different
stages. During the first two months after the initiation of TX administration, both non-recombined
Sertoli cells (SOX9+) and transdifferentiated cells (FOXL2+) remain alive, whereas recombined but
not yet transdifferentiated cells (SOX9  , WT1+) do undergo apoptosis. In the second stage (P180
and older mice), massive apoptosis affects all cell types, including the remaining Sertoli cells and
granulosa-like cells.
Discussion
The battle of sexes persists beyond the sex determination stage
There is now compelling evidence that the bipotential nature of the genital ridge at the beginning
of gonad development is not completely lost once either testes or ovaries acquire their final adult
morphology and functionality. During embryonic development the newly formed Sertoli cells can
transdifferentiate to their ovarian counterparts when the testis promoting factors Sox9 or Dmrt1 are
lost (Georg et al., 2012; Matson et al., 2011a). The finding that Foxl2 in the adult ovary was neces-
sary to prevent granulosa-to-Sertoli cell transdifferentation revealed that this antagonism also oper-
ates in the adult gonad. In the adult testis, the same antagonism also appears to exist, as FOXL2+
cells were observed when Dmrt1 was ubiquitously deleted (Matson et al., 2011a). Here we show
that Sertoli-to-granulosa cell transdifferentiation can be induced as well in the adult mouse testis by
just deleting two SoxE genes, Sox9 and Sox8. These results evidence that Sox9 has a crucial role,
not only during sex determination and testis differentiation, but also in adult testis maintenance,
where, together with Sox8 and coordinately with Dmrt1, it prevents male-to-female genetic
reprogramming.
The regulatory relationship between Dmrt1 and Sox9 requires further discussion. At the sex
determination stage of the mouse (E11.5), both Sox9 and Dmrt1 are expressed in the early embry-
onic testis (Kent et al., 1996; Raymond et al., 1999), but whereas early embryonic Sox9 mutants
show sex reversal (Chaboissier et al., 2004; Barrionuevo et al., 2006), early embryonic Dmrt1 KO
mice have testes that express Sox9 and appear histologically normal until P7 (Raymond et al.,
2000). Thus, Sox9 expression is independent of DMRT1 during sex determination and some time
thereafter. Similarly, Sertoli cell-specific inactivation of Sox9/8 at E13.5, shortly after the sex determi-
nation stage, leads to a rapid downregulation of Dmrt1 that becomes already visible four days later,
at E17.5 (Georg et al., 2012). In contrast, Dmrt1 ablation at E13.5 results in a very delayed Sox9
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downregulation, which is seen at P14 (one month later), coinciding with Foxl2 upregulation
(Matson et al., 2011a). This suggests again that Sox9 expression is independent of Dmrt1 in newly
differentiated Sertoli cells and that the loss of Sox9 after Dmrt1 ablation is a secondary consequence
of the upregulation of ovarian genes(s), such as Foxl2, in the same cells. On the other hand, several
observations suggest the transactivation of SOX9 by DMRT1: 1) DMRT1 binds near the Sox9 locus in
P28 mouse testes (Matson et al., 2011a), 2) ectopic expression of Dmrt1 in embryonic XX gonads
causes XX sex reversal with upregulation of Sox9 (Zhao et al., 2015) and 3) FOXL2-/- sex reversed
polled goats undergo a process of transdifferentiation in which DMRT1 expression precedes the
upregulation of SOX9 (Elzaiat et al., 2014). In the latter two cases, however, female-promoting
genes, including FOXL2, are either downregulated or not expressed, and thus, SOX9 upregulation
could be again an indirect consequence of the downregulation of female-promoting genes. Here we
provide evidence that in the adult gonad, mutant Sox9/8 Sertoli cells lose DMRT1, and that FOXL2
protein appears concomitant with the loss of DMRT1, consistent with the notion that Dmrt1 expres-
sion is SOX9/8-dependent and that DMTR1 represses Foxl2. Additional observations support this
view: 1) nearly all the genes strongly affected by the loss of DMRT1 were also affected by the loss of
SOX9/8; 2) Sertoli-to-granulosa cell transdifferentiation observed in the testes of our Sox9/8 mutant
mice may be reduced by decreasing levels of RA, a signaling pathway known to be blocked by
DMRT1 in Sertoli cells to prevent Foxl2 expression and transdifferentiation into granulosa-like cells
(Minkina et al., 2014); 3) DMRT1 can silence Foxl2 in the absence of SOX9 and SOX8
(Lindeman et al., 2015); and 4) Sox9 is upregulated in the adult ovary after the ectopic expression
of Dmrt1, coinciding with Foxl2 downregulation (Lindeman et al., 2015). Altogether, available data
suggest that, like at earlier stages, a main role for SOX9/8 in adult male sex maintenance is to keep
Dmrt1 actively expressed, this latter gene having a fundamental role in repressing female-specific
genes. However, these observations do not rule out the possibility that DMRT1 is also necessary for
the maintenance of Sox9 expression in the adult testis and that a feed-forward regulatory loop
between Sox9/8 and Dmrt1 exists that ensures testis maintenance and antagonizes the feminizing
action of Foxl2. Additional experiments (e.g. a time course of Sox9 expression in adult SC-DKO
Dmrt1 mice) will help to clarify this issue.
There is evidence that Wt1 acts upstream of both Sox9 and Sox8 during the early stages of
embryonic testis development (Gao et al., 2006; Barrionuevo et al., 2009). In the adult testis, we
have seen that Sox9/8-depleted Sertoli cells initially maintain WT1 expression, but this expression
becomes progressively downregulated coinciding with the time-point at which Foxl2 is upregulated.
This suggests that Wt1 retains its hierarchical position also in the adult testis, and that female-spe-
cific factors, including Foxl2, may be involved in its silencing. Consistent with previous studies
(Chun et al., 1999; Schmidt et al., 2004), we detected two types of granulosa cells in the normal
adult ovary (Figure 3Ce): 1) those located in antral (mature) follicles express FOXL2 but not WT1,
and 2) those located in pre-antral follicles express both proteins. Thus, considering these two molec-
ular markers, transdifferentiation of Sox9/8 SC-DKO Sertoli cells seems to give rise to mature folli-
cle-type granulosa cells. This expression pattern also suggests that WT1 may play an anti-feminizing
role in adult Sertoli cells.
SOX9 and SOX8 are necessary to maintain tubular architecture and
function in adult testes
We have reported here that the functional redundancy between the Sox9 and Sox8 alleles observed
in embryonic Sertoli cells (Barrionuevo et al., 2009) and other embryonic cell types
(Chaboisier et al., 2004; Stolt et al., 2004; Reginensi et al., 2011) is also maintained in adult Ser-
toli cells. The phenotype of mutant testes becomes ever more severe as the numbers of null alleles
increase in their genotype, with extreme phenotypes observed in homozygous DKO testes 4 months
after the beginning of TX treatment, at which stage seminiferous tubules have literally disappeared.
As Sertoli cell proliferation stops once they obtain their adult appearance (Kluin et al., 1984), pro-
grammed cell death in Sox9/8 mutants may explain their reduction in number. Consistently, we
found no SOX9+ apoptotic cell by P90 (30 datx), indicating that Sox9/8 initially protects Sertoli cells
from apoptosis, a role previously shown for this gene in other developing organs (Akiyama et al.,
2002; Cheung et al., 2005; Seymour et al., 2007). Similarly, newly differentiated FOXL2+ cells did
also not apoptose, showing that reprogrammed granulosa-like cells are also protected from apopto-
sis. However, the situation was substantially different in P150 (90 datx) mutant testes, where
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apoptosis was intense. At these late stages of testis regression, cord structure was dramatically com-
promised and even Sertoli cells still expressing Sox9 were seen to undergo apoptosis. It is well
known that the number of Sertoli cells must reach a critical threshold to organize embryonic testicu-
lar cords (Palmer and Burgoyne, 1991; Schmahl and Capel, 2003). Accordingly, our results suggest
that adult testis tubules also require the presence of a minimum number of Sertoli cells to be main-
tained. The progressive loss of Sertoli cells after Sox9/8 ablation, either by apoptosis or by transdif-
ferentiation into granulosa-like cells, appears to reach a point of no return at which the remaining
normal Sertoli cells are unable to support the tubular structure and are also induced to apoptose.
Hence, our results show that SOXE factors are necessary to maintain Sertoli cell identity and seminif-
erous tubule integrity, as these cells maintain all the other cell types forming the tubules, which
become completely disorganized in their absence.
Several findings suggest that deregulation of important structural proteins controlled by SoxE
genes could be involved in the process. SOX9 controls, either directly (Bell et al., 1997) or indirectly
(Barrionuevo et al., 2008; Georg et al., 2012), the expression of extracellular matrix proteins, which
contribute importantly to the tubular structure. Sox8-/- mice show increased BTB permeability and
greatly reduced levels of a-tubulin acetylation, suggesting that impairment of the Sertoli cell cytoskel-
eton may have modified the microenvironment of the seminiferous epithelium (Singh et al., 2013).
Also, after Sox9 ablation in Sox8 mutants, both developing (Barrionuevo et al., 2009; Georg et al.,
2012) and adult testes (present paper) experience downregulation and/or abnormal distribution of
several important proteins required for the formation of Sertoli–Sertoli and/or Sertoli–germ cell adhe-
sion complexes (Figure 2—figure supplement 2). In this context, it is noteworthy that spermatogene-
sis is halted when the functionality of the BTB is impaired (Meng et al., 2005; Dadhich et al., 2013).
Thus, in our Sox9/8 SC-DKO mouse testes, BTB permeation and cytoskeleton impairment may give
rise to a damaged intra-tubular microenvironment in which spermatogenesis is not supported any-
more, germ cells undergoing both apoptosis and desquamation. Altogether, available data strongly
suggest that failure of Sox9/8 double mutant Sertoli cells to sustain testis tubule architecture is a direct
consequence of altered expression of cell adhesion molecules and probably of other structural ele-
ments such as components of the cytoskeleton or the extracellular matrix.
Regarding the somatic cells of the testis, PM cells disappear in Sox9/8 mutant testes, whereas
Leydig cells appear not to be affected, as they express the Leydig cell markers HSD17b3 and
Insl3. Although PM and Leydig cell specification is induced by Sertoli cells during early testis
development (reviewed by Svingen and Koopman, 2013), at later stages of testis development
(E14.5 and onward) Leydig cells do not require Sertoli cells for proliferation and synthesis of tes-
tosterone (Gao et al., 2006). Our results in the adult testis show that adult PM cells retain their
original dependence from Sertoli cells, whereas maintenance of adult Leydig cells is again Sertoli
cell-independent. Further research is required to unravel the actual functional status of Leydig
cells in Sox9/8 mutant testes.
A regulatory model for adult testis maintenance in mice
According to the above considerations, we propose a model for the maintenance of Sertoli cell fate
in the adult testis. In this model, Sox9/8 play a central role in maintaining active Dmrt1, which pre-
vents expression of ovary promoting genes, including Foxl2, which in turn negatively regulates Sox9/
8 and/or Dmrt1. Dmrt1 inhibits RA signaling which promotes the expression of Foxl2, although an
interference of Sox9 on this signaling pathway, through a Dmrt1-independent mechanism, cannot be
ruled out. Wt1 positively regulates Sox8/9 and is negatively regulated by Foxl2 and/or other ovar-
ian-specific genes. Sox9/8 are also needed for maintaining the expression of important testis struc-
tural genes and for protecting Sertoli cells from apoptosis (Figure 7, solid lines). It is also possible
that Dmrt1 may establish feed-forward regulatory loop with Sox9/8 and that Sox9/8 repress the
expression of ovary-specific mRNAs through Dmrt1-independent mechanisms, although these inter-
actions are less strongly supported by available data (Figure 7, dashed lines).
In conclusion, we have shown Sox9/8 have important DMRT1-dependent and independent func-
tions in the maintenance of the adult testis. In their absence, phenotypically normal, fertile testes are
genetically reprogrammed and Sertoli-to-granulosa cell transdifferentiation occurs. Nevertheless,
this is a mere transient stage of mutant adult Sertoli cells in the irreversible degenerative process the
seminiferous tubules face in the absence of Sox9 and Sox8.
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Material and methods
Mouse lines and crosses
Previously generated Sox9f/f; Sox8-/- mice (Barrionuevo et al., 2009; Kist et al., 2002;
Sock et al., 2001) were bred to Wt1-CreERT2 mice (Zhou et al., 2008) and the resulting double
heterozygous offspring harboring the Cre allele was backcrossed to Sox9f/f; Sox8-/- mice to
obtain heterozygous and homozygous compound Sox9; Sox8 conditional mutants. The same
mating scheme was followed with the Sox9-CreERT2 mouse line (Kopp et al., 2011). To report
CRE activity, the R26R-EYFP reporter allele (Srinivas et al., 2001) was crossed into Wt1-
CreERT2; Sox9f/f; Sox8-/- and Sox9-CreERT2; Sox9f/f; Sox8-/- mice. For genotyping we performed
PCR and qPCR with DNA purified from tail tips. Primers and PCR conditions for Sox9flox, Sox8-,
Cre, and R26R-EYFP were used as described Barrionuevo et al. (2009). Mouse housing and
handling, as well as laboratory protocols, were approved by the University of Granada Ethics
Committee for Animal Experimentation.
Tamoxifen administration
Tamoxifen (Sigma, T5648) dissolved in corn oil (Sigma, C8267) at a concentration of 30 mg/ml and
0.16 mg of TX per gram of body weight was initially administered orally to mice with a feeding nee-
dle for 5 consecutive days. With this treatment Sox9/8 double mutants displayed a 90% lethality, so
we reduced the dose of TX (down to 0.07 mg TX / gr of body weight) and 90% of Sox9/8 double
mutants survived, but the efficiency of CRE recombination fell then to below 20%. Then, we tried to
feed mice with a TX-supplemented diet (40 mg TX/100 g Harlan 2914 diet) for one month. This
treatment resulted in a 100% survival rate. TX administrations were started at 2 months (P60) and fin-
ished 30 days after the beginning of TX administration (P90 [30 datx]) (Figure 1A). All results pre-
sented here, except those included in Figure 1—figure supplement 2 and 3, were obtained from
mice fed with the TX-supplemented diet.
Figure 7. Model for the regulation of mammalian sex maintenance. Positive regulation is indicated by arrows. Negative regulation is indicated by
perpendicular lines. See text for a detailed explanation.
DOI: 10.7554/eLife.15635.027
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Histological and immunostaining methods
Gonads were dissected out, weighted and prepared for standard histological methods, including
haematoxylin and eosin staining. Single and multiple immunofluorescence were performed as pre-
viously described (Dadhich et al., 2013). Table 1 summarizes the antibodies used.
Analysis of apoptosis
To perform the TUNEL technique we used the Fluorescent In Situ Cell Death Detection Kit (Roche,
Mannheim, Germany) according to the manufacturer’s instruction.
Analysis of BTB Permeability
The in vivo test to analyze the permeability of the BTB in the testes of control and mutant mice was
performed using a biotin-labelled tracer compound (EZ-Link Sulfo-NHS-LC-Biotin tracer, Thermo Sci-
entific) as described (Dadhich et al., 2013).
WIN 18,446 treatment
TX-treated Sox9-CreERT2; Sox9f/f; Sox8-/-mice were injected subcutaneously either with 40 mg/ml
WIN 18,446 (Tocris, Biotechne, UK, Cat. No 4736), dissolved in 50 ml dimethyl sulfoxide or with the
vehicle alone for 8 days, 4 days before and 4 days after the end of the 30 days diet TX treatment. Fif-
teen days after the end of WIN 18,446 treatment, gonads were collected and processed for double
immunofluorescense for ACTA2 and FOXL2 as described above. The number of FOXL2+ cells per
transversal ST section was counted in 20 tubules of 5 WIN 18,446-treated and 5 control animals.
Only circular or ellipsoid tubular sections in which the major/minor axis ratio was lower than two
were used for counts.
Transcriptome analysis
Both testes were extracted from six P150 (90 datx) mutant males (three Wt1-CreERT2; Sox9f/f;
Sox8-/- and three Sox9-CreERT2; Sox9f/f; Sox8-/-). As controls, both gonads were also extracted
from two P150 (not treated) and two P150 (90 datx) Sox9f/f male mice as well as from two 4–5
months old normal females. All TX-treated mice were euthanized three months after the initiation
of diet TX-treatment for one month. The two gonads of each individual were pooled, homoge-
nized in 1 ml of RNAzol (Molecular Research Center, Inc.) per 100 mg of tissue and the total
RNAs were then individually purified from the twelve samples following the RNAzol
Table 1. Antibodies used in this study.
Gene product Raised in Working dilution References
Laminin rabbit 1:100 Sigma L9393
ACTA2 mouse 1:200 Sigma A2547
Claudin11 rabbit 1:100 Santa Cruz Biotechnology, CA sc-25711
DMC1 goat 1:100 Santa Cruz Biotechnology, CA sc-8973
PCNA mouse 1:100 Santa Cruz Biotechnology, CA sc-56
CYP14A1 (P450scc) goat 1:200 Santa Cruz Biotechnology, CA sc-18043
SOX9 rabbit 1:100 Santa Cruz Biotechnology, CA sc-20095
SOX9 goat 1:10 Santa Cruz Biotechnology, CA sc-17341
WT1 rabbit 1:100 Santa Cruz Biotechnology, CA sc-192
FOXL2 goat 1:100 Abcam ab5096
GFP rabbit 1:100 Novus Biologicals NB600-308
WT1 mouse 1:30 DAKO M3561 (clone 6F-H2)
CYP19A1 (Aromatase) mouse 1:10 GeneTex GTX41561
DMRT1 rabbit 1:400 Gift from Dr. Silvana Guioli
DOI: 10.7554/eLife.15635.028
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manufacturer’s instructions. After successfully passing Macrogen Inc. quality check, the twelve
RNAs were paired-end sequenced separately in an Illumina HiSeq 2000 platform at that company
and the quality of the resulting sequencing reads was assessed using FastQC (http://www.bioin-
formatics.bbsrc.ac.uk/projects/fastqc/).
Bioinformatics
RNAseq data were processed with the Tuxedo tools (Trapnell et al., 2012). Alignments were done
with Tophat/Bowtie2 against the mm10 UCSC annotated mouse genome. Differential expression
analyses where done with Cuffdiff. Analysis of the resulting data were performed with the CummeR-
bund Bioconductor package. The quality of RNA-seq was checked as described in the package doc-
umentation. Briefly, by comparing FPKM scores across samples, and looking for outliers replicates,
by analyzing squared coefficient of variation which allows visualization of cross-replicate variability
between conditions and by analyzing the dispersion plots (Figure 8).
To explain the presence of both Sox9 and Sox8 transcripts in the transcriptome of double homo-
zygotes for the null allele, their transcripts where visualised with the IGV genome browser
(Robinson et al., 2011). Recombinant Sox9 locus is seen by Cuffkinks and IGV as an alternative
spliced transcript. Sashimi plots show that the CRE recombination is not 100% effective as transcripts
with the correct splicing still remain in both mutant conditions but a high proportion of the Sox9
genes are efficiently deleted. These plots also show that in the absence of the 2nd and 3rd exons
after recombination, alternative intron donor and acceptor sites downstream of Sox9 can be used
Figure 8. Pairwise scatterplots comparing log10 FPKM between different conditions. Dispersion is lower when comparing similar conditions (controls,
mutants) and higher when comparing mutant with control conditions. Notice that dispersion observed when mutants are compared with ovary is lower
than that observed comparing them with any of the testis controls.
DOI: 10.7554/eLife.15635.029
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for splicing. Sox8 transcripts only include the 5’ untranslated portion of the transcripts demonstrat-
ing that these individuals are actually Sox8 /  (Figure 9).
For Sox9/8 DKO and Dmrt1 KO transcriptome comparison CEL files corresponding to the Dmrt1
conditional knockout expression analysis of P28 testes by Matson et al. (2011a) were downloaded
from the GEO database (Acc: GSE27261). Files were processed with the simpleaffy (Miller, 2016)
package from Bioconductor and normalized with gcrma (Wu and Gentry, 2016). Uninformative data,
control probes and genes with low variation or close to background were filtered out. Data were
grouped in two conditions, Control and Mutant. Differential expression was analyzed with the limma
package (Richie et al., 2015) and annotated with the Affymetrix Mouse Genome 430 2.0 Array annota-
tion data. Genes with log2FC having p values less than 0.05 for differential expression tests respect to
normal testes where selected. These genes list was then selected from our transcriptome data and
those showing non-significative log2FC where filtered out. The remaining 8910 genes showing signifi-
cant differential expression in both experiments are included in Figure 5—source data 1.
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